A daily serving of blueberries may help combat depression in older adults, according to findings from a recent pilot study. Depression affects up to one in three individuals over the age of 65, often linked to underlying health conditions, limited mobility, or sleep disturbances common with aging.
Researchers in Boston investigated the potential mood-boosting effects of blueberries. The study involved 18 participants aged 65 and older who were experiencing depressive symptoms. Participants were divided into two groups: one consumed 48 grams of freeze-dried blueberry powder daily for three months, while the other received a placebo.
Both groups reported improvements in mood and a reduction in depressive symptoms. However, the researchers noted that the magnitude of these improvements appeared stronger in the blueberry group, with less variability compared to the placebo group, although the difference was not statistically significant.
Scientists hypothesize that blueberries may influence the gut-brain axis, a communication pathway between the digestive system and the brain. Research suggests that gut microbes play a role in producing neurotransmitters like GABA and serotonin, which are crucial for mood regulation. The study observed subtle changes in the gut microbiome of participants who consumed blueberries, including an increase in bacterial enzymes that could potentially enhance GABA production. GABA is known for its calming effect on the nervous system, and lower levels have been associated with depression.
Lead researchers emphasized that the study's small sample size and homogeneous demographic (primarily white women) necessitate further investigation with larger, more diverse populations to confirm these findings.
While some experts advise caution regarding supplements marketed for mood enhancement, the potential benefits of blueberries might stem from anthocyanins, the pigments responsible for their blue color. Previous research suggests these compounds can inhibit monoamine oxidase (MAO), an enzyme that breaks down key mood neurotransmitters such as serotonin, dopamine, and noradrenaline.